Clinical Trials Logo

Filter by:
NCT ID: NCT06286319 Not yet recruiting - Lung Diseases Clinical Trials

Cold Oxygen Lung Preservation and Ventilation With the "Angel Cooler"

Start date: April 2024
Phase: N/A
Study type: Interventional

The objective of this feasibility study is to evaluate continuous temperature monitoring, oxygen (O2) concentration and ventilation with positive end expiratory pressure (PEEP) to keep lungs cooled at 4-8 degrees Celsius, with continuous O2 concentration of 100% and inflated with a PEEP of 8-10 during the entire cold ischemic period.

NCT ID: NCT06286189 Recruiting - Clinical trials for Obstructive Sleep Apnea

Trazodone on OSA Endotypes

Start date: January 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. Some OSA patients with low arousal threshold wake up prematurely during an obstructive event and do not have time for spontaneous upper airway (UA) dilator muscle recruitment. As a consequence they are exposed to apnea and hypopnea cycling. In this protocol the investigators will test the effect of trazodone administered before sleep on OSA traits and OSA severity during sleep.

NCT ID: NCT06286033 Recruiting - Healthy Volunteers Clinical Trials

A Safety Study of Single and Multiple Doses of AG-181 in Healthy Participants

Start date: February 20, 2024
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to assess the safety and tolerability of AG-181 in healthy participants after oral administration of single ascending dose (SAD) of AG-181 in Part 1 and multiple ascending dose (MAD) in Part 2 along with the effect of food on the pharmacokinetics (PK) of single oral doses of AG-181 in healthy participants in Part 3.

NCT ID: NCT06285968 Recruiting - Blood Pressure Clinical Trials

The DREAM Study: A Multidimensional Sleep Health Intervention for Reducing Cardiometabolic Health Inequities

Start date: March 12, 2024
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to evaluate the impact of a multidimensional sleep health promotion intervention on blood pressure, glycemic control indicators, anthropometric markers of adiposity, and lifestyle factors in Hispanic/Latina/o/x adults. Participants will be randomized into an intervention or a control group. The control arm will receive standard Life's Essential 8 cardiovascular health educational materials. The intervention arm will additionally receive a multi-component intervention aimed at improving sleep health based on evidence-based sleep hygiene education and established behavior change techniques that include personalized sleep health feedback, goal setting and establishing a sleep health plan, coaching, self-monitoring, and addressing light and noise in the sleep environment. Mixed methods will be used to understand implementation determinants, processes, and outcomes, ensuring the successful completion and future expansion of this intervention.

NCT ID: NCT06285929 Enrolling by invitation - Neoplasms Clinical Trials

ACS Community Access to Resources Education and Support

ACS CARES
Start date: September 1, 2023
Phase:
Study type: Observational

The goal of this study is to evaluate the pilot phase of ACS Cares to identify key implementation outcomes and assess effectiveness of the program to improve distress, enhance communication, and reduce missed appointments and healthcare utilization.

NCT ID: NCT06285916 Not yet recruiting - Clinical trials for Postpartum Depression

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression

NuMom
Start date: February 2024
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to test the study drug, NORA520, as a possible treatment for severe postpartum depression (PPD). The trial aims to determine: - How well NORA520 is tolerated and what side effects it may cause - If NORA520 reduces depressive symptoms in subjects with severe PPD - The amount of NORA520 in the blood at various times after taking the study drug; this provides information that helps determine how often NORA520 should be taken - In a subset of subjects, the amount of NORA520 in breastmilk at various times after taking it to determine if and how much NORA520 can pass into breastmilk Participate in this study will be randomly assigned to one of 3 different groups. All subjects will take the study drug for 3 days.

NCT ID: NCT06285890 Recruiting - Clinical trials for Acute Myeloid Leukemia

Phase I Study of HC-7366 With Azacitidine and Venetoclax for Acute Myeloid Leukemia

Start date: May 20, 2024
Phase: Phase 1
Study type: Interventional

To find a recommended dose of HC-7366 that can be given in combination with azacitidine and venetoclax to patients with AML. The safety and effects of this drug combination will also be studied.

NCT ID: NCT06285825 Not yet recruiting - Cytopenia Clinical Trials

A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

Start date: July 31, 2024
Phase: Early Phase 1
Study type: Interventional

To look at the safety and effectiveness of emapalumab for the treatment of prolonged severe cytopenia in participants with LBCL who receive CART.

NCT ID: NCT06285812 Recruiting - Otitis Media Acute Clinical Trials

Otitis Treatment With OtoSightâ„¢ - Modification of Antibiotic Treatment Intervention in Children

OTO-MATIC
Start date: January 10, 2023
Phase:
Study type: Observational

A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.

NCT ID: NCT06285747 Recruiting - Breast Carcinoma Clinical Trials

A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder Function

Start date: July 28, 2023
Phase:
Study type: Observational

This study evaluates how swelling in the chest following breast cancer treatment may affect patients' quality of life and shoulder function.